Related Experiment Video
Updated: May 15, 2026
06:33
Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes
M Colombo1, L Mirandola, N Platonova
1Department of Health Science, Università degli Studi di Milano, Milan, Italy.
Leukemia
|January 12, 2013
Summary
Multiple myeloma, a deadly blood cancer, remains incurable. Research explores Notch signaling
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Multiple myeloma is a fatal hematopoietic malignancy with limited curative options.
- The bone marrow microenvironment plays a critical role in multiple myeloma progression, therapy resistance, and bone destruction.
- The Notch signaling pathway is increasingly recognized for its involvement in multiple myeloma pathogenesis.
Purpose of the Study:
- To review the evidence of Notch pathway deregulation in multiple myeloma.
- To elucidate the role of Notch signaling in the interaction between myeloma cells and the bone marrow niche.
- To discuss the therapeutic implications of targeting Notch signaling in multiple myeloma.
Main Methods:
- Literature review of studies on Notch signaling in multiple myeloma.
- Analysis of molecular mechanisms underlying Notch pathway involvement.
- Evaluation of preclinical and clinical data regarding Notch inhibitors.
Main Results:
- Notch signaling is frequently deregulated in multiple myeloma.
- Notch pathway activation influences multiple myeloma cell growth, drug resistance, angiogenesis, and bone lesions.
- The interaction between myeloma cells and the bone marrow stroma is modulated by Notch signaling.
Conclusions:
- Notch signaling is a key player in multiple myeloma pathogenesis and progression.
- Targeting Notch signaling presents a potential therapeutic strategy for multiple myeloma.
- Further research is needed to determine the efficacy and safety of Notch inhibition in multiple myeloma treatment.
More Related Videos
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
03:14Notch Signaling Pathway
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
03:14Notch Signaling Pathway
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...